IC

Ikarian Capital Portfolio holdings

AUM $302M
1-Year Return 65.21%
This Quarter Return
-5.26%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$329M
AUM Growth
-$20.7M
Cap. Flow
+$40.1M
Cap. Flow %
12.19%
Top 10 Hldgs %
37.77%
Holding
184
New
15
Increased
124
Reduced
11
Closed
9

Top Buys

1
SAGE
Sage Therapeutics
SAGE
$8.27M
2
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$7.11M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
$6.52M
4
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
$6.34M
5
BLU
BELLUS Health Inc.
BLU
$5.94M

Top Sells

1
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
$11.3M
2
BIIB icon
Biogen
BIIB
$6M
3
BCYC
Bicycle Therapeutics
BCYC
$5.89M
4
GBT
Global Blood Therapeutics, Inc.
GBT
$3.95M
5
IBB icon
iShares Biotechnology ETF
IBB
$3.67M

Sector Composition

1 Healthcare 98.75%
2 Consumer Staples 0.62%
3 Technology 0.36%
4 Financials 0.23%
5 Real Estate 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
TGTX icon
151
TG Therapeutics
TGTX
$5.06B
$21K ﹤0.01%
2,292
-98,447
-98% -$902K
KPTI icon
152
Karyopharm Therapeutics
KPTI
$58.4M
$6K ﹤0.01%
55
+3
+6% +$327
BXRX
153
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$4K ﹤0.01%
74
+6
+9% +$324
BLUE
154
DELISTED
bluebird bio
BLUE
$1K ﹤0.01%
15
+1
+7% +$67
TSVT
155
DELISTED
2seventy bio
TSVT
$1K ﹤0.01%
99
+6
+6% +$61
AKBA icon
156
Akebia Therapeutics
AKBA
$801M
– –
0
– –
ALLK
157
DELISTED
Allakos
ALLK
– –
0
– –
APLS icon
158
Apellis Pharmaceuticals
APLS
$3.62B
– –
0
– –
ATHA icon
159
Athira Pharma
ATHA
$15.3M
– –
0
– –
AVIR icon
160
Atea Pharmaceuticals
AVIR
$264M
– –
0
– –
BBIO icon
161
BridgeBio Pharma
BBIO
$9.91B
– –
-1,500
Closed -$25K
BPMC
162
DELISTED
Blueprint Medicines
BPMC
– –
0
– –
IOVA icon
163
Iovance Biotherapeutics
IOVA
$796M
– –
-172,521
Closed -$3.29M
MDGL icon
164
Madrigal Pharmaceuticals
MDGL
$9.61B
– –
-23,700
Closed -$2.01M
NBIX icon
165
Neurocrine Biosciences
NBIX
$13.9B
– –
0
– –
NKTR icon
166
Nektar Therapeutics
NKTR
$684M
– –
0
– –
PMVP icon
167
PMV Pharmaceuticals
PMVP
$76.3M
– –
0
– –
PTGX icon
168
Protagonist Therapeutics
PTGX
$3.71B
– –
0
– –
RCUS icon
169
Arcus Biosciences
RCUS
$1.23B
– –
0
– –
RFL icon
170
Rafael Holdings
RFL
$50.9M
– –
-73,530
Closed -$370K
SRPT icon
171
Sarepta Therapeutics
SRPT
$1.93B
– –
0
– –
UTHR icon
172
United Therapeutics
UTHR
$17.2B
– –
0
– –
XBI icon
173
SPDR S&P Biotech ETF
XBI
$5.28B
– –
0
– –
DCPH
174
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
– –
0
– –
MRTX
175
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
0
– –
4 5 6
7
8